PMID- 36832096 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230228 IS - 2075-4418 (Print) IS - 2075-4418 (Electronic) IS - 2075-4418 (Linking) VI - 13 IP - 4 DP - 2023 Feb 7 TI - Comparative Study of the Impact of Human Leukocyte Antigens on Renal Transplant Survival in Andalusia and the United States. LID - 10.3390/diagnostics13040608 [doi] LID - 608 AB - Renal transplantation is the treatment of choice for patients suffering from chronic renal disease, one of the leading causes of death worldwide. Among the biological barriers that may increase the risk of acute renal graft rejection is the presence of human leukocyte antigen (HLA) incompatibilities between donor and recipient. This work presents a comparative study of the influence of HLA incompatibilities on renal transplantation survival in the Andalusian (South of Spain) and United States (US) population. The main objective is to analyse the extent to which results about the influence of different factors on renal graft survival can be generalised to different populations. The Kaplan-Meier estimator and the Cox model have been used to identify and quantify the impact on the survival probability of HLA incompatibilities, both in isolation and in conjunction with other factors associated with the donor and recipient. According to the results obtained, HLA incompatibilities considered in isolation have negligible impact on renal survival in the Andalusian population and a moderate impact in the US population. Grouping by HLA score presents some similarities for both populations, while the sum of all HLA scores (aHLA) only has an impact on the US population. Finally, the graft survival probability of the two populations differs when aHLA is considered in conjunction with blood type. The results suggest that the disparities in the renal graft survival probability between the two populations under study are due not only to biological and transplantation-associated factors, but also to social-health factors and ethnic heterogeneity between populations. FAU - Talaminos Barroso, Alejandro AU - Talaminos Barroso A AUID- ORCID: 0000-0002-5047-5296 AD - Biomedical Engineering Group, Department of Signal Theory and Communications, University of Seville, 41004 Seville, Spain. FAU - Reina Tosina, Javier AU - Reina Tosina J AUID- ORCID: 0000-0002-6853-4899 AD - Biomedical Engineering Group, Department of Signal Theory and Communications, University of Seville, 41004 Seville, Spain. AD - Department of Signal Theory and Communications, University of Seville, 41004 Seville, Spain. FAU - Roa, Laura M AU - Roa LM AD - Biomedical Engineering Group, Department of Signal Theory and Communications, University of Seville, 41004 Seville, Spain. FAU - Calvillo Arbizu, Jorge AU - Calvillo Arbizu J AUID- ORCID: 0000-0003-1277-3310 AD - Biomedical Engineering Group, Department of Signal Theory and Communications, University of Seville, 41004 Seville, Spain. AD - Department of Telematics Engineering, University of Seville, 41004 Seville, Spain. FAU - Perez Valdivia, Miguel Angel AU - Perez Valdivia MA AD - Urology and Nephrology Department, University Hospital Virgen del Rocio, 41012 Seville, Spain. FAU - Medina, Rafael AU - Medina R AD - Urology and Nephrology Department, University Hospital Virgen del Rocio, 41012 Seville, Spain. FAU - Rocha Castilla, Jose Luis AU - Rocha Castilla JL AUID- ORCID: 0000-0003-2650-1914 AD - Urology and Nephrology Department, University Hospital Virgen del Rocio, 41012 Seville, Spain. FAU - Castro-de-la-Nuez, Pablo AU - Castro-de-la-Nuez P AD - Autonomous Regional Transplant Coordination in Andalusia, 41012 Seville, Spain. LA - eng PT - Journal Article DEP - 20230207 PL - Switzerland TA - Diagnostics (Basel) JT - Diagnostics (Basel, Switzerland) JID - 101658402 PMC - PMC9954912 OTO - NOTNLM OT - blood type OT - human leukocyte antigens OT - renal transplantation OT - socio-economic factors OT - survival analysis COIS- The authors declare no conflict of interest. EDAT- 2023/02/26 06:00 MHDA- 2023/02/26 06:01 PMCR- 2023/02/07 CRDT- 2023/02/25 01:49 PHST- 2022/11/08 00:00 [received] PHST- 2023/01/23 00:00 [revised] PHST- 2023/01/27 00:00 [accepted] PHST- 2023/02/25 01:49 [entrez] PHST- 2023/02/26 06:00 [pubmed] PHST- 2023/02/26 06:01 [medline] PHST- 2023/02/07 00:00 [pmc-release] AID - diagnostics13040608 [pii] AID - diagnostics-13-00608 [pii] AID - 10.3390/diagnostics13040608 [doi] PST - epublish SO - Diagnostics (Basel). 2023 Feb 7;13(4):608. doi: 10.3390/diagnostics13040608.